Clinical Trial Update: Efficacy and Safety Study of QLM3003 Ointment in Participants With Mild or Moderate Atopic Dermatitis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update evaluating the efficacy and safety of QLM3003 Ointment in mild to moderate atopic dermatitis, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• QLM3003 Ointment

Snippet

Sponsor: Qilu Pharmaceutical Co., Ltd. | Conditions: Atopic Dermatitis | Phase 3 | Status: RECRUITING